“We need to build flexible operating theatres”

Flexible operating theatres, micro-sensors on surgeons to monitor their well-being and 3D images projected onto organs to be operated on. These are a few ideas ...

Swedish breakthrough in Alzheimer’s: “We can finally present great data”

Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes ...

Hallengren tar plats i global grupp mot antibiotikaresistens

Socialministern en av 26 ledamöter i gruppen.

Pharma Outsourcing igång på Stockholm Waterfront

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Lif vill ha "nationell ingång" för hälsodata även i Sverige

Sverige behöver förbättra tillgängligheten till hälsodata för forskning och innovation, anser branschorganisationen Lif, som tycker att vi borde snegla mot våra...

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Rätt läkemedel till rätt patient – ett paradigmskifte på väg

Ett nytt sätt att se på läkemedel mot cancer har gjort sitt intåg – läkemedel som förskrivs vid en viss genmutation istället för vid en viss cancersjukdom. Det ...

Samuel Lagercrantz: Immunotherapy against cancer is still in its early stages

For more than 100 years, researchers have tried to target the body’s own immune system to fight cancer cells. They have occasionally been laughed at and ridicul...

Cellodlingsplatta med glasbotten

Glasklart. Den nya Cellview odlingsplattan för celler levereras med en inbyggd högtransparent nyhet, en glasbotten.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Will the industry follow the economic revival?

Welcome to the eleventh Biotech Forum + Scanlab Fair!

Changeable proteins cause nerve disease

An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

How critical are the “Spermageddon” reports? – Researchers call for action

A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden s...

Pilots want to live too

"Konsulter ger oss nya perspektiv"

Pernilla Sandwall, Chief Operating Officer på Index Pharmaceutcals, berättade på Life Science Swedens event Pharma Outsourcing om bolagets modell för outsourcing.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Academy for a new turn at work

Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.